论文信息 - Phase I study of anti-epidermal growth factor receptor (anti-EGFR) antibody C225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck (SCCHN) - 字舞流文

Phase I study of anti-epidermal growth factor receptor (anti-EGFR) antibody C225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)

S. Spencer | R. Meredith | A. Lobuglio | M. Saleh | G. Peters | F. Robert | H. Waksal | J. Newsome | M. Ezekiel | M. B. Khazaeli | M. P. Ezekiel | M. Saleh